Charles Schwab Investment Management Inc Agios Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 464,958 shares of AGIO stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

464,958

Previous 472,547 1.61%

Holding current value

$16 Million

Previous $15.5 Million 12.26%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$29.3 - $35.9 $222,357 - $272,445	-7,589 Reduced 1.61%	464,958 $13.6 Million
Q4 2024 Feb 06, 2025	BUY	$32.86 - $61.64 $227,621 - $426,980	6,927 Added 1.49%	472,547 $15.5 Million
Q3 2024 Nov 12, 2024	BUY	$41.19 - $49.72 $333,350 - $402,383	8,093 Added 1.77%	465,620 $20.7 Million
Q2 2024 Aug 12, 2024	BUY	$27.55 - $48.83 $476,477 - $844,514	17,295 Added 3.93%	457,527 $19.7 Million
Q1 2024 May 08, 2024	SELL	$21.32 - $34.81 $344,573 - $562,599	-16,162 Reduced 3.54%	440,232 $12.9 Million
Q4 2023 Feb 06, 2024	BUY	$19.97 - $24.53 $93,839 - $115,266	4,699 Added 1.04%	456,394 $10.2 Million
Q3 2023 Nov 08, 2023	BUY	$24.36 - $28.18 $351,271 - $406,355	14,420 Added 3.3%	451,695 $11.2 Million
Q2 2023 Aug 09, 2023	BUY	$21.38 - $29.19 $159,558 - $217,844	7,463 Added 1.74%	437,275 $12.4 Million
Q1 2023 May 11, 2023	BUY	$21.74 - $30.93 $804 - $1,144	37 Added 0.01%	429,812 $9.87 Million
Q4 2022 Feb 13, 2023	BUY	$24.81 - $31.52 $228,549 - $290,362	9,212 Added 2.19%	429,775 $12.1 Million
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $565,341 - $989,274	28,977 Added 7.4%	420,563 $11.9 Million
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $62,473 - $115,060	-3,662 Reduced 0.93%	391,586 $8.68 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $256,474 - $334,628	9,613 Added 2.49%	395,248 $11.5 Million
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $738,494 - $1.24 Million	-24,966 Reduced 6.08%	385,635 $12.7 Million
Q3 2021 Nov 16, 2021	BUY	$41.92 - $58.18 $1.47 Million - $2.04 Million	35,095 Added 9.35%	410,601 $19 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $5.13 Million - $6.04 Million	98,579 Added 35.6%	375,506 $20.7 Million
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $455,392 - $592,020	10,296 Added 3.86%	276,927 $14.3 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $111,784 - $156,653	3,366 Added 1.28%	266,631 $11.6 Million
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $495,755 - $818,647	-14,637 Reduced 5.27%	263,265 $9.22 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $943,551 - $1.46 Million	27,389 Added 10.93%	277,902 $14.9 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $374,331 - $639,047	-11,876 Reduced 4.53%	250,513 $8.89 Million
Q4 2019 Feb 07, 2020	BUY	$30.08 - $50.59 $894,970 - $1.51 Million	29,753 Added 12.79%	262,389 $12.5 Million
Q3 2019 Nov 08, 2019	BUY	$32.4 - $49.58 $658,206 - $1.01 Million	20,315 Added 9.57%	232,636 $7.54 Million
Q2 2019 Aug 09, 2019	BUY	$46.17 - $68.1 $160,533 - $236,783	3,477 Added 1.66%	212,321 $10.6 Million
Q1 2019 May 14, 2019	BUY	$45.92 - $67.67 $1.15 Million - $1.7 Million	25,052 Added 13.63%	208,844 $14.1 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $45,336 - $81,198	1,061 Added 0.58%	183,792 $8.48 Million
Q3 2018 Nov 13, 2018	BUY	$71.67 - $91.95 $1.09 Million - $1.4 Million	15,228 Added 9.09%	182,731 $14.1 Million
Q2 2018 Aug 08, 2018	BUY	$73.22 - $99.55 $1.15 Million - $1.56 Million	15,691 Added 10.34%	167,503 $14.1 Million
Q1 2018 May 07, 2018	BUY	$59.83 - $86.53 $1.79 Million - $2.58 Million	29,837 Added 24.46%	151,812 $12.4 Million
Q4 2017 Jan 17, 2018	BUY	$52.12 - $72.33 $311,677 - $432,533	5,980 Added 5.16%	121,975 $6.97 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $6.37 Million - $7.79 Million	115,995	115,995 $7.74 Million

Others Institutions Holding AGIO

# of Institutions

237

Shares Held

60.1M

Call Options Held

323K

Put Options Held

367K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.88B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Agios Pharmaceuticals, Inc. Transaction History